A recent study suggests that exposure to nanoparticles may have caused the death of two female workers and the illnesses of five others in China. Life science health industry companies that manufacture, integrate, sell or buy products that contain nanomaterials may want to monitor reaction to this report, which may garner attention from media outlets, scientists, regulators and the plaintiffs' bar. For a full discussion of these issues, review the full Client Alert written by Reed Smith attorneys Antony Klapper, Jesse Ash and David Wagner.… Continue Reading
This post was written by Antony B. Klapper and Jesse J. Ash. On April, 8, 2009, the National Institute for Occupational Safety and Health (“NIOSH”) and the Centers for Disease Control and Prevention (“CDC”) submitted a notice for public comment in the Federal Register, requesting information to evaluate potential health risks associated with the use … Continue Reading
Reed Smith LLP, in conjunction with ChemRisk and the Center for Business Intelligence, is presenting a complimentary webinar, “Nanotechnology – What the Life Sciences Industry Needs to Know about Managing its Risks”, October 22 at noon eastern. The moderator for this event will be Reed Smith partner Antony B. Klapper. Speakers include: Barr Weiner, Associate … Continue Reading
